Predictors for Uptake of Vaccines Offered during the Second Year of Life: Second Dose of Measles-Containing Vaccine and Meningococcal Serogroup A-Containing Vaccine, Ghana, 2020
Vaccines · 23.09.2023 · 11 (10) · 1515
DOI: 10.3390/vaccines11101515 ↗Kurz gefasst
Fachartikel in der Zeitschrift Vaccines, online erschienen am 23.09.2023. Verfasst von Pierre Muhoza und 10 weiteren Autor:innen. Beteiligte Einrichtung: Global Immunization Division, Center for Global Health, Centers for Disease Control and Prevention, Atlanta, GA 30329, USA. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: United States Centers for Disease Control and Prevention.
Abstract (Originalsprache)
Background
Understanding the drivers of coverage for vaccines offered in the second year of life (2YL) is a critical focus area for Ghana’s life course approach to vaccination. This study characterizes the predictors of vaccine receipt for 2YL vaccines—meningococcal serogroup A conjugate vaccine (MACV) and the second dose of measles-containing vaccine (MCV2)—in Ghana.
Methods
1522 children aged 18–35 months were randomly sampled through household surveys in the Greater Accra Region (GAR), Northern Region (NR), and Volta Region (VR). The association between predictors and vaccination status was modeled using logistic regression with backwards elimination procedures. Predictors included child, caregiver, and household characteristics.
Results
Coverage was high for infant vaccines (>85%) but lower for 2YL vaccines (ranging from 60.2% for MACV in GAR to 82.8% for MCV2 in VR). Predictors of vaccination status varied by region. Generally, older, first-born children, those living in rural settlements and those who received their recommended infant vaccines by their first birthday were the most likely to have received 2YL vaccines. Uptake was higher among those with older mothers and children whose caregivers were aware of the vaccination schedule.
Conclusions
Improving infant immunization uptake through increased community awareness and targeted strategies, such as parental reminders about vaccination visits, may improve 2YL vaccination coverage.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Global Immunization Division, Center for Global Health, Centers for Disease Control and Prevention, Atlanta, GA 30329, USA.
- Epidemic Intelligence Service, Centers for Disease Control and Prevention, Atlanta, GA 30329, USA.
- Expanded Programme on Immunisation, Disease Control and Prevention Department, Public Health Division, Ghana Health Service, Accra 00233, Ghana.
- Neglected Tropical Diseases Control Programme, Disease Control and Prevention Department, Public Health Division, Ghana Health Service, Accra 00233, Ghana.
ORCID-Profile: Monica P Shah, Melissa T Wardle, Aaron S Wallace
Förderung
- United States Centers for Disease Control and Prevention
Zitieren
APA
Muhoza, P., Shah, M. P., Gao, H., Amponsa-Achiano, K., Quaye, P., Opare, W., Okae, C., Aboyinga, P. N., Opare, K. L., Wardle, M. T., & Wallace, A. S. (2023). Predictors for Uptake of Vaccines Offered during the Second Year of Life: Second Dose of Measles-Containing Vaccine and Meningococcal Serogroup A-Containing Vaccine, Ghana, 2020. Vaccines, 11(10), 1515. https://doi.org/10.3390/vaccines11101515
Vancouver
Muhoza P, Shah MP, Gao H, Amponsa-Achiano K, Quaye P, Opare W, et al. Predictors for Uptake of Vaccines Offered during the Second Year of Life: Second Dose of Measles-Containing Vaccine and Meningococcal Serogroup A-Containing Vaccine, Ghana, 2020. Vaccines. 2023;11(10):1515. doi:10.3390/vaccines11101515
BibTeX
@article{Muhoza2023,
author = {Muhoza, Pierre and Shah, Monica P and Gao, Hongjiang and Amponsa-Achiano, Kwame and Quaye, Pamela and Opare, William and Okae, Charlotte and Aboyinga, Philip-Neri and Opare, Kwadwo L and Wardle, Melissa T and Wallace, Aaron S},
title = {Predictors for Uptake of Vaccines Offered during the Second Year of Life: Second Dose of Measles-Containing Vaccine and Meningococcal Serogroup A-Containing Vaccine, Ghana, 2020},
journal = {Vaccines},
year = {2023},
volume = {11},
number = {10},
pages = {1515},
doi = {10.3390/vaccines11101515}
}
EUVIMED